Role of Cdk Phosphorylation of HsCdc6 in DNA Replication
Role of Cdk Phosphorylation of HsCdc6 in DNA Replication
批准号:
0233887
负责人:
Wei Jiang
金额:
$16.19万
依托单位国家:
美国
项目类别:
Continuing Grant
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-03-01 至 2004-02-29
中文摘要
在所有真核细胞中,染色体的精确复制和姐妹染色单体精确分离成两个子染色体对于它们的身份的忠实传播是必不可少的。 第一个事件,DNA复制,是一个严格调控的过程,严格耦合到细胞周期的进展。 它发生在细胞周期S期的离散染色体位置(复制起点)。 当DNA复制开始时,细胞必须确保其所有基因组都被复制,并且每个DNA片段的复制在每个细胞周期中只发生一次。 HsCdc 6是芽殖酵母DNA复制蛋白Cdc 6p的人类蛋白质同源物,在人类细胞中DNA复制的起始中起重要作用。 与所有Cdc 6相关蛋白一样,HsCdc 6包含一个二分的步行者核苷酸结合基序,并与真核和原核细胞的钳加载器显示出显着的序列相似性,该钳加载器将环形DNA聚合酶持续合成因子加载到DNA上。 最近的研究表明,HsCdc 6具有内在的ATP结合和ATP酶活性,这在调节DNA复制的起始中起重要作用。 HsCdc 6是细胞周期蛋白依赖性激酶(Cdk)的生理底物。 HsCdc 6的Cdk磷酸化是启动DNA复制所必需的,并通过受体依赖的核输出导致其核排斥。 因此,它表明,Cdk磷酸化的HsCdc 6阻止其与染色质的再结合,从而防止DNA再复制。 然而,确切的机制,由Cdk磷酸化的HsCdc 6是需要的启动和磷酸化的HsCdc 6是如何从细胞核特异性输出尚不清楚。 确定这些机制是本项目的目标。 该项目的第一个目的是确定HsCdc 6的Cdk磷酸化如何调节DNA复制的启动。 重组HsCdc 6及其Cdk磷酸化突变体将使用基于杆状病毒的表达系统从昆虫细胞中纯化。 纯化的HsCdc 6蛋白将用于确定HsCdc 6的Cdk磷酸化是否调节其内在ATP结合和/或ATP酶活性。 此外,Cdk磷酸化的HsCdc 6在调节DNA复制的起始的功能作用将使用爪蟾无细胞DNA复制系统确定。 本项目的第二个目的是通过体外结合蛋白纯化或酵母双杂交筛选策略确定调节Cdk磷酸化HsCdc 6核输出的核质转运途径,并确定特异性调节该过程的因子。 这将最终导致阐明HsCdc 6的Cdk磷酸化阻止哺乳动物细胞中DNA再复制的分子机制。 这些研究将有助于更好地理解HsCdc 6的Cdk磷酸化在调节DNA复制起始和阻止DNA再复制中的功能作用。 结果也将导致更好地理解DNA复制和核质运输的基本生物学过程,这在高等真核生物中仍然是个谜。
英文摘要
In all eukaryotic cells, accurate duplication of chromosomes and precise segregation of the sister chromatids into two daughter chromosomes are essential for faithful propagation of their identity. The first event, DNA replication, is a tightly regulated process that is strictly coupled to the progression of the cell cycle. It occurs at discrete chromosomal locations (replication origins) during the S-phase of the cell cycle. When DNA replication is initiated, the cell must ensure that all of its genome is replicated and that the replication of every DNA section occurs once and only once per cell cycle. HsCdc6, a human protein homolog to the budding yeast DNA replication protein Cdc6p, plays an essential role in the initiation of DNA replication in human cells. Like all Cdc6-related proteins, HsCdc6 contains a bipartite Walker nucleotide-binding motif and shows significant sequence similarity to the eukaryotic and prokaryotic clamp loaders that load ring-shaped DNA polymerase processivity factors onto DNA. Recent studies have shown that HsCdc6 has intrinsic ATP binding and ATPase activity, which play important roles in regulating the initiation of DNA replication. HsCdc6 is a physiological substrate of cyclin-dependent kinase (Cdk). Cdk phosphorylation of HsCdc6 is required for the initiation of DNA replication and results in its nuclear exclusion via a receptor-dependent nuclear export. Therefore, it is suggested that Cdk phosphorylation of HsCdc6 prevents its reassociation with chromatin, thereby preventing DNA re-replication. Nevertheless, the exact mechanisms by which phosphorylation of HsCdc6 by Cdk is needed for the initiation and how phosphorylated HsCdc6 is specifically exported from the nucleus are unclear. Determination of these mechanisms is the goal of this project. The first aim of the project is to determine how Cdk phosphorylation of HsCdc6 regulates the initiation of DNA replication. Recombinant HsCdc6 and its Cdk phosphorylation mutants will be purified from insect cells using the baculovirus-based express system. Purified HsCdc6 proteins will be used to determine whether Cdk phosphorylation of HsCdc6 regulates its intrinsic ATP binding and/or ATPase activity. Moreover, the functional roles of Cdk phosphorylation of HsCdc6 in regulating the initiation of DNA replication will be determined using the Xenopus cell-free DNA replication system. The second aim of this project is to determine the nucleocytoplasmic transport pathway that regulates the nuclear export of Cdk phosphorylated HsCdc6 and identify factor(s) that specifically regulates the process by in vitro binding protein purification or yeast two-hybrid screen strategies. This will ultimately lead to elucidation of the molecular mechanism by which Cdk phosphorylation of HsCdc6 prevents DNA re-replication in mammalian cells. These studies will contribute to a better understanding of the function roles of Cdk phosphorylation of HsCdc6 in regulating the initiation of DNA replication and preventing DNA re-replication. The results will also lead to a better understanding of the fundamental biological processes of DNA replication and nucleocytoplasmic transport, which are still enigmatic in higher eukaryotes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TWC SBE: Medium: Collaborative: Building a Privacy-Preserving Social Networking Platform from a Technological and Sociological Perspective
-
批准号:1855391
-
项目类别:Standard Grant
-
资助金额:$30.9万
-
财政年份:2018
-
负责人:Wei Jiang
-
依托单位:
TWC SBE: Medium: Collaborative: Building a Privacy-Preserving Social Networking Platform from a Technological and Sociological Perspective
-
批准号:1564101
-
项目类别:Standard Grant
-
资助金额:$34.37万
-
财政年份:2016
-
负责人:Wei Jiang
-
依托单位:
I-Corps: An Outsourced and Completely Private Social Network: You&Me
-
批准号:1522781
-
项目类别:Standard Grant
-
资助金额:$5.0万
-
财政年份:2015
-
负责人:Wei Jiang
-
依托单位:
TC:Large:Collaborative Research:Anonymizing Textual Data and its Impact on Utility
-
批准号:1011984
-
项目类别:Standard Grant
-
资助金额:$35.7万
-
财政年份:2010
-
负责人:Wei Jiang
-
依托单位:
Collaborative Research: Predatory Lending, Predatory Borrowing, and the Mortgage Crisis: Evidence from Loan-Level Data from a Large Bank
-
批准号:0851428
-
项目类别:Continuing Grant
-
资助金额:$24.76万
-
财政年份:2009
-
负责人:Wei Jiang
-
依托单位:
STTR Phase I: Fully Embedded Optical Interconnect Layers Based on Molded Polymer Lightwave Components for Large Field Size Printed Circuit Boards
-
批准号:0539538
-
项目类别:Standard Grant
-
资助金额:$10.0万
-
财政年份:2006
-
负责人:Wei Jiang
-
依托单位:
CAREER: Data Quality Management through Statistical Quality Control and Data Mining
-
批准号:0542881
-
项目类别:Continuing Grant
-
资助金额:$0.0万
-
财政年份:2006
-
负责人:Wei Jiang
-
依托单位:
Role of Cdk Phosphorylation of HsCdc6 in DNA Replication
-
批准号:0078432
-
项目类别:Continuing Grant
-
资助金额:$30.0万
-
财政年份:2000
-
负责人:Wei Jiang
-
依托单位:
国内基金
海外基金
登录
查看更多内容
细胞周期蛋白A2(CCNA2)通过CDK2促进三阴性乳腺癌的增殖及迁移
-
批准号:JCZRLH202601137
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
抗LAG3抗体改善免疫微环境逆转CDK4/6抑制剂 耐药的机制研究
-
批准号:JCZRLH202600287
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
姜黄素脂质体协同CDK4/6抑制剂通过ROS/DNA损伤通路阻遏乳腺癌转移的机制研究
-
批准号:JCZRLH202600107
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
环状RNAcircWEE1通过miR-942介导的IGF1和CDK6通路双重调控骨肉瘤顺铂耐药的作用机制研究
-
批准号:2026JJ80942
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:龚昊立
-
依托单位:
基于力学微环境探讨ERK/CDK5/P-MIEF1轴阻滞AECII分化在肺纤维化中的作用及机制研究
-
批准号:2026JJ60258
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:邵敏
-
依托单位:
槐耳联合CDK4/6抑制剂调控Cyclin D1-CDK4/6-Rb通路在乳腺癌中的作用及机制研究
-
批准号:2026JJ82715
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:廖妮
-
依托单位:
基于“去宛陈莝,精生形盛”探讨白芍七物颗粒通过CDK4/6-CCND1/2/3-ATM通路时序调控UC肠黏膜细胞周期与DNA损伤修复的机制研究
-
批准号:2026JJ81083
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:杨宗亮
-
依托单位:
淫羊藿苷通过介导RASSF1α去甲基化抑制cyclinD1/ CDK4/6通路活化改善肺腺癌代谢-免疫失衡的机制研究
-
批准号:2026JJ81663
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:曾赛丽
-
依托单位:
BK多瘤病毒通过大T抗原调控CDK1建立移
植肾小管上皮细胞内病毒复制微环境的
机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:陈徐涛
-
依托单位:
B3GAT3介导CDK4蛋白糖基化修饰促进肝癌细胞衰老抵抗与HCC发生发展的机制与转化研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位: